People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vernal Biosciences, Inc. | — | Biotechnology | Series C | $42.5M | $828.0M | 2022 |
| FloDesign Sonics, Inc. | — | Other Technology | Series A | $16.8M | $172.5M | 2017 |
| RoosterBio, Inc. | — | Biotechnology | Series A | $13.5M | $42.2M | 2024 |
| Virica Biotech Inc. | — | Biotechnology | Seed | $7.0M | $18.6M | 2024 |
Daniella Kranjac at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniella Kranjac on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Anderson | 1 | 21 |
| Stephen Davis | 1 | 8 |
| Errik Anderson | 1 | 8 |
| Rob Roy | 1 | 5 |
| ROBERT CARLSON | 1 | 4 |
| Nety Krishna | 1 | 3 |
| Susan Riley | 1 | 3 |
| Timothy Kelly | 1 | 3 |
| Robert Roy | 1 | 3 |
| Steve Davis | 1 | 3 |
| Michael Harsh | 1 | 2 |
| Boris Ryabov | 1 | 2 |
| Rob Carlson | 1 | 2 |
| Susan Dexter | 1 | 2 |
| Gustavo Mahler | 1 | 2 |
| Jon Rowley | 1 | 1 |
| Martin Westberg | 1 | 1 |
| Robert Preti | 1 | 1 |
| Christian Cobaugh | 1 | 1 |
| Uplaksh Kumar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.